Matches in Wikidata for { <http://www.wikidata.org/entity/Q92015718> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q92015718 description "article scientifique publié en 2019" @default.
- Q92015718 description "articolo scientifico (pubblicato il 2019)" @default.
- Q92015718 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q92015718 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q92015718 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92015718 description "scientific article published on 01 February 2019" @default.
- Q92015718 description "wetenschappelijk artikel" @default.
- Q92015718 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q92015718 name "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 name "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 name "[Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China]" @default.
- Q92015718 type Item @default.
- Q92015718 label "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 label "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 label "[Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China]" @default.
- Q92015718 prefLabel "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 prefLabel "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 prefLabel "[Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China]" @default.
- Q92015718 P1433 Q92015718-FED9E908-4603-4980-A8E3-C76DFDA300C6 @default.
- Q92015718 P1476 Q92015718-CCAAC29F-5495-4EB9-80B2-24BA1A6A1751 @default.
- Q92015718 P2093 Q92015718-107E5B17-3AC7-4A81-BA25-F7F883F59393 @default.
- Q92015718 P2093 Q92015718-1BC79B5A-4B14-46A4-8C74-2429A4A32202 @default.
- Q92015718 P2093 Q92015718-20A49E7A-CCD6-4650-B7F9-5C47CD5441C3 @default.
- Q92015718 P2093 Q92015718-45D5E89D-DD38-466B-879A-C243C1DC800F @default.
- Q92015718 P2093 Q92015718-49FC5368-0545-40C7-8681-C7A63733663B @default.
- Q92015718 P2093 Q92015718-606DC0F4-A2D5-4B53-9BE6-66D0AF4AE006 @default.
- Q92015718 P2093 Q92015718-C2A81961-9EF0-4365-8CBA-0CC0E712C592 @default.
- Q92015718 P2093 Q92015718-DCBF6796-1B75-4197-8865-60CF4077EB53 @default.
- Q92015718 P2093 Q92015718-ED4525A2-1B63-4E04-B22D-A422501155D5 @default.
- Q92015718 P304 Q92015718-50377740-2292-46A0-8ED3-38028BA48FBF @default.
- Q92015718 P31 Q92015718-AA0B71F8-8A96-4A53-B6A2-7947DE1CEAA1 @default.
- Q92015718 P356 Q92015718-3FA80BD6-4319-4527-9223-411170C26B69 @default.
- Q92015718 P433 Q92015718-E079C910-6E8F-427E-AAD6-4C7197034CE8 @default.
- Q92015718 P478 Q92015718-991F92B5-36D6-43F3-AD36-7E218B4C0E1A @default.
- Q92015718 P577 Q92015718-5D5B710D-81A5-4FFD-9B60-1D3EA87706A5 @default.
- Q92015718 P698 Q92015718-4D79D827-09E5-4261-8A7E-35C1DFB1E88E @default.
- Q92015718 P921 Q92015718-4E4FE12B-C111-40E9-A643-831EA0BBD37E @default.
- Q92015718 P921 Q92015718-7795105A-D8CE-4EA6-A1A5-515392F1BF24 @default.
- Q92015718 P921 Q92015718-8CC4942F-F226-4E76-974D-3403356F9BCF @default.
- Q92015718 P921 Q92015718-E5F937A8-B422-4F62-8C31-3AB7E8435DD6 @default.
- Q92015718 P921 Q92015718-F6FAB774-F7A0-48B4-8F94-6F17617EC299 @default.
- Q92015718 P356 CMA.J.ISSN.1007-3418.2019.02.010 @default.
- Q92015718 P698 30818917 @default.
- Q92015718 P1433 Q27714398 @default.
- Q92015718 P1476 "Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China" @default.
- Q92015718 P2093 "C S Lin" @default.
- Q92015718 P2093 "J P Li" @default.
- Q92015718 P2093 "J Yuan" @default.
- Q92015718 P2093 "L Tao" @default.
- Q92015718 P2093 "X H Zhang" @default.
- Q92015718 P2093 "Y J Guan" @default.
- Q92015718 P2093 "Y S Jie" @default.
- Q92015718 P2093 "Y T Chong" @default.
- Q92015718 P2093 "Z X Zhao" @default.
- Q92015718 P304 "123-127" @default.
- Q92015718 P31 Q13442814 @default.
- Q92015718 P356 "10.3760/CMA.J.ISSN.1007-3418.2019.02.010" @default.
- Q92015718 P433 "2" @default.
- Q92015718 P478 "27" @default.
- Q92015718 P577 "2019-02-01T00:00:00Z" @default.
- Q92015718 P698 "30818917" @default.
- Q92015718 P921 Q16824572 @default.
- Q92015718 P921 Q19462214 @default.
- Q92015718 P921 Q19598175 @default.
- Q92015718 P921 Q422618 @default.
- Q92015718 P921 Q55779873 @default.